BETRF (BetterLife Pharma) Days Payable: 0.00 (As of Apr. 2026)

What is BetterLife Pharma Days Payable?

BetterLife Pharma BETRF -10.07% 28 Days Payable is 0.00 as of Apr. 2026. GuruFocus rates BETRF with a GF Score™ of 28/100. The stock has 2 warning signs investors should review. Among 705 Biotechnology companies, BetterLife Pharma ranks worse than 141843.83% on this metric.

BetterLife Pharma's average Accounts Payable for the three months ended in Apr. 2026 was $2.86 Mil. BetterLife Pharma's Cost of Goods Sold for the three months ended in Apr. 2026 was $0.00 Mil.

The historical rank and industry rank for BetterLife Pharma's Days Payable or its related term are showing as below:

BETRF's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 113.36
* Ranked among companies with meaningful Days Payable only.

BetterLife Pharma's Days Payable stayed the same from Jan. 2025 (0.00) to Apr. 2026 (0.00). stayed the same

BetterLife Pharma Days Payable Related Terms

BetterLife Pharma Days Payable Historical Data

* Premium members only.

The historical data trend for BetterLife Pharma's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BetterLife Pharma Days Payable Chart

BetterLife Pharma Annual Data

Trend

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

Jan25

Jan26

Days Payable

Get a 7-Day Free Trial

0.00

BetterLife Pharma Quarterly Data
	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25	Apr25	Jul25	Jan26	Apr26
Days Payable	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

BETRF vs VRTX, REGN, ALNY: Days Payable Comparison

For the Biotechnology subindustry, BetterLife Pharma's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BetterLife Pharma Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BetterLife Pharma's Days Payable distribution charts can be found below:

* The bar in red indicates where BetterLife Pharma's Days Payable falls into.

Save Embed

28GF Score

BetterLife Pharma Inc BETRF

Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

BetterLife Pharma Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

BetterLife Pharma's Days Payable for the fiscal year that ended in Jan. 2026 is calculated as

	Days Payable (A: Jan. 2026 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Jan. 2025 )	+	Accounts Payable (A: Jan. 2026 ))	/	count )	/	Cost of Goods Sold (A: Jan. 2026 )	*	Days in Period
=	( (3.124	+	2.869)	/	2 )	/	0	*	365
=	2.9965					/	0	*	365
=	N/A

BetterLife Pharma's Days Payable for the quarter that ended in Apr. 2026 is calculated as:

	Days Payable (Q: Apr. 2026 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jan. 2026 )	+	Accounts Payable (Q: Apr. 2026 ))	/	count )	/	Cost of Goods Sold (Q: Apr. 2026 )	*	Days in Period
=	( (2.869	+	2.854)	/	2 )	/	0	*	365 / 4
=	2.8615					/	0	*	365 / 4
=	N/A

Frequently Asked Questions Learn more about Days Payable →

What does a Days Payable of 0.00 mean?

BetterLife Pharma (BETRF) has a Days Payable of 0.00 as of Apr. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on BetterLife Pharma and its competitors. According to the industry distribution chart, BetterLife Pharma ranks #999999 out of 705 companies in the Biotechnology industry.

Is BetterLife Pharma's Days Payable too high?

BetterLife Pharma's current Days Payable is 0.00. Based on the distribution chart, BetterLife Pharma ranks #999999 out of 705 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, BetterLife Pharma has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.

How does BetterLife Pharma's Days Payable compare to VRTX and REGN?

According to the Biotechnology industry distribution chart, BetterLife Pharma ranks #999999 out of 705 companies for Days Payable. This places BetterLife Pharma in the lower half of its industry. The industry median Days Payable is 113.36. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Days Payable for a Biotechnology company?

The median Days Payable among Biotechnology companies is 113.36, based on 705 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Days Payable mean?

A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on BetterLife Pharma and its competitors. For the Biotechnology industry, the median Days Payable is 113.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BetterLife Pharma's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is BetterLife Pharma stock overvalued right now?

BetterLife Pharma (BETRF) has a current Days Payable of 0.00. The current Days Payable is 0.00. BetterLife Pharma's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Days Payable calculated?

Days Payable is calculated from a company's financial statements. For BetterLife Pharma (BETRF), the current Days Payable is 0.00 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BetterLife Pharma Business Description

Industry Healthcare Biotechnology

Comparable Companies XCNQ:LOBE TSXV:GSD TSXV:TTI TSX:RVX TSXV:SHRX TSXV:ALZI XCNQ:MDMA TSX:MDNA XCNQ:QNTM XCNQ:BLAB VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges NPAU:Germany BETR:Canada

Address 1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6

Website https://www.abetterlifepharma.com

BetterLife Pharma Inc is a biopharmaceutical company engaged in the development of patented pharmaceuticals. It is an emerging biotechnology company mainly focused on developing compounds for the treatment of mental disorders. It is also refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight viral infections. The Company operates in one industry segment, development and commercialization of patented pharmaceuticals within one geographical area.

28GF Score

Get the complete analysis for BETRF

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.10

Price

View BETRF Analysis

See Days Payable data for all stocks →